1E Therapeutics vs VILYA
1E Therapeutics vs VILYA, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: 1E Therapeutics is on 48/100 and VILYA on 62/100.
Where each one leads
1E Therapeutics
- agent readiness: 32/100 against 26/100
- domain rating: 20/100 against 10/100
VILYA
- our overall score: 62/100 against 48/100
- headcount growth: +123.1% against +18.6%
- LinkedIn following: 4,799 against 3,258
At a glance
| Measure | 1E Therapeutics | VILYA |
|---|---|---|
| What it is | Drug development company creating first-in-class RNA-targeting therapeutics using a proprietary platform. | AI-powered platform for designing novel molecular structures for new medicines. |
| Category | Drug Development, Life Sciences, Therapeutics, RNA-Targeting | BIO + LIFE SCIENCES, Biotech, Drug Discovery, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Platform |
| Founded | 2020 | 2022 |
| Headquarters | Not published | San Francisco, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | 1E Therapeutics | VILYA |
|---|---|---|
| Employees | 49 | 47 |
| Headcount growthLast 12 months | +18.6% | +123.1% |
| Total funding | $120M | $121M |
| Latest round | Seed | Series A |
| LinkedIn followers | 3,258 | 4,799 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | 1E Therapeutics | VILYA |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 48/100 | 62/100 |
| Traction | 57/100 | 57/100 |
| Team | 50/100 | 70/100 |
| Search visibility | 39/100 | 34/100 |
| Quality | 45/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (32/100) | F (26/100) |
| Domain ratingLink authority, 0-100 | 20/100 | 10/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | 1E Therapeutics | VILYA |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Svelte, Astro, Tailwind CSS |
1E Therapeutics vs VILYA: common questions
Which is better, 1E Therapeutics or VILYA?
On our 0-100 score VILYA rates higher (62/100 against 48/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do 1E Therapeutics and VILYA compare on the numbers?
1E Therapeutics leads on agent readiness (32/100 against 26/100), domain rating (20/100 against 10/100). VILYA leads on our overall score (62/100 against 48/100), headcount growth (+123.1% against +18.6%), LinkedIn following (4,799 against 3,258).
Read the full 1E Therapeutics review and pricing or the VILYA review and pricing. You can also browse other 1E Therapeutics alternatives we track.